173 related articles for article (PubMed ID: 37263346)
1. Transcription Factor Forkhead Box O1 Mediates Transforming Growth Factor-β1-Induced Apoptosis in Hepatocytes.
Chen Y; Pan Q; Liao W; Ai W; Yang S; Guo S
Am J Pathol; 2023 Sep; 193(9):1143-1155. PubMed ID: 37263346
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation.
Pan Q; Gao M; Kim D; Ai W; Yang W; Jiang W; Brashear W; Dai Y; Li S; Sun Y; Qi Y; Guo S
Cell Mol Gastroenterol Hepatol; 2024; 17(1):41-58. PubMed ID: 37678798
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.
Yadav H; Devalaraja S; Chung ST; Rane SG
J Biol Chem; 2017 Feb; 292(8):3420-3432. PubMed ID: 28069811
[TBL] [Abstract][Full Text] [Related]
5. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
[TBL] [Abstract][Full Text] [Related]
6. Dehydroabietic acid reverses TNF-α-induced the activation of FOXO1 and suppression of TGF-β1/Smad signaling in human adult dermal fibroblasts.
Wang XW; Yu Y; Gu L
Int J Clin Exp Pathol; 2014; 7(12):8616-26. PubMed ID: 25674226
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin Gallate Inhibits Hepatic Glucose Production in Primary Hepatocytes via Downregulating PKA Signaling Pathways and Transcriptional Factor FoxO1.
Li X; Chen Y; Shen JZ; Pan Q; Yang W; Yan H; Liu H; Ai W; Liao W; Guo S
J Agric Food Chem; 2019 Apr; 67(13):3651-3661. PubMed ID: 30875211
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
[TBL] [Abstract][Full Text] [Related]
9. Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice.
Niu L; Cui X; Qi Y; Xie D; Wu Q; Chen X; Ge J; Liu Z
PLoS One; 2016; 11(5):e0156090. PubMed ID: 27224286
[TBL] [Abstract][Full Text] [Related]
10. Redirecting TGF-
Qiao X; Rao P; Zhang Y; Liu L; Pang M; Wang H; Hu M; Tian X; Zhang J; Zhao Y; Wang XM; Wang C; Yu H; Guo F; Cao Q; Wang Y; Wang YM; Zhang GY; Lee VW; Alexander SI; Zheng G; Harris DCH
J Am Soc Nephrol; 2018 Feb; 29(2):557-570. PubMed ID: 29180394
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 transcription factor regulates chondrogenic differentiation through transforming growth factor β1 signaling.
Kurakazu I; Akasaki Y; Hayashida M; Tsushima H; Goto N; Sueishi T; Toya M; Kuwahara M; Okazaki K; Duffy T; Lotz MK; Nakashima Y
J Biol Chem; 2019 Nov; 294(46):17555-17569. PubMed ID: 31601652
[TBL] [Abstract][Full Text] [Related]
12. FoxO1 is a crucial mediator of TGF-β/TAK1 signaling and protects against osteoarthritis by maintaining articular cartilage homeostasis.
Wang C; Shen J; Ying J; Xiao D; O'Keefe RJ
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30488-30497. PubMed ID: 33199631
[TBL] [Abstract][Full Text] [Related]
13. FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation.
Vivar R; Humeres C; Muñoz C; Boza P; Bolivar S; Tapia F; Lavandero S; Chiong M; Diaz-Araya G
Biochim Biophys Acta; 2016 Jan; 1863(1):128-38. PubMed ID: 26518453
[TBL] [Abstract][Full Text] [Related]
14. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes.
Valverde AM; Fabregat I; Burks DJ; White MF; Benito M
Hepatology; 2004 Dec; 40(6):1285-94. PubMed ID: 15565601
[TBL] [Abstract][Full Text] [Related]
15. FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress.
Ponugoti B; Xu F; Zhang C; Tian C; Pacios S; Graves DT
J Cell Biol; 2013 Oct; 203(2):327-43. PubMed ID: 24145170
[TBL] [Abstract][Full Text] [Related]
16. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
[TBL] [Abstract][Full Text] [Related]
17. [Effects of over-expressed forkhead transcription factor O1 on high glucose induced extracellular matrix secretion in rat mesangial cells].
Guo F; Wang Q; Qin G; Zhou Y; Wu L; Liu F
Zhonghua Yi Xue Za Zhi; 2014 Jun; 94(24):1899-904. PubMed ID: 25154998
[TBL] [Abstract][Full Text] [Related]
18. Forkhead transcription factor FoxO1 inhibits insulin- and transforming growth factor-beta-stimulated plasminogen activator inhibitor-1 expression.
Jung YA; Lee KM; Kim MK; Jung GS; Seo YJ; Kim HS; Cho HC; Lee KU; Park KG; Lee IK
Biochem Biophys Res Commun; 2009 Sep; 386(4):757-61. PubMed ID: 19563779
[TBL] [Abstract][Full Text] [Related]
19. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
[TBL] [Abstract][Full Text] [Related]
20. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1).
Kaur S; Wang F; Venkatraman M; Arsura M
J Biol Chem; 2005 Nov; 280(46):38599-608. PubMed ID: 16157589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
